BLOG

Araris Biotech AG Nabs $24M to Bring ADC, Linker Programs to Clinic

Araris Biotech AG secured $24 million in financing to advance the development of its proprietary antibody-drug conjugate-linker technology and drive its own ADC candidates into the clinic.